Lincoln Pharmaceuticals Limited (NSE:LINCOLN)
India · Delayed Price · Currency is INR 604.90
+10.05 (1.69%)
Apr 2, 2026, 3:29 PM IST
Lincoln Pharmaceuticals Market Cap
Lincoln Pharmaceuticals has a market cap or net worth of 12.24 billion as of April 2, 2026. Its market cap has increased by 17.09% in one year.
Market Cap
12.24B
Enterprise Value
9.92B
Revenue
6.52B
Ranking
n/a
PE Ratio
13.93
Stock Price
604.90
Market Cap Chart
Since October 21, 2004, Lincoln Pharmaceuticals's market cap has increased from 138.90M to 12.24B, an increase of 8,708.31%. That is a compound annual growth rate of 23.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 12.24B | 26.42% |
| Dec 31, 2025 | 9.68B | -38.62% |
| Dec 31, 2024 | 15.77B | 29.24% |
| Dec 29, 2023 | 12.20B | 71.47% |
| Dec 30, 2022 | 7.12B | -0.74% |
| Dec 31, 2021 | 7.17B | 47.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharma Advanced Research Company | 39.05B |
| RPG Life Sciences | 30.72B |
| Orchid Pharma | 26.34B |
| Solara Active Pharma Sciences | 20.50B |
| Windlas Biotech | 16.18B |
| Indoco Remedies | 15.14B |
| Jagsonpal Pharmaceuticals | 12.32B |
| Beta Drugs | 12.01B |